Naturgy-backed study flags risk Spain misses 2030 PNIEC targets at current pace
Bitget2026/10/08 12:37Naturgy-backed analysis by EY flagged Spain’s current execution pace as insufficient to meet many 2030 PNIEC energy-transition targets. Emissions cuts are tracking below plan, with the widest shortfalls in transport, buildings, agriculture, waste, and broader energy-efficiency goals. Renewables capacity is rising, but electricity demand is undershooting projections, weakening economics for new build and complicating system integration. Report called for faster grid buildout, more storage, clearer regulatory signals, and stronger electrification to align demand with supply. Biomethane outlook was more constructive, with the project pipeline seen as capable of approaching 2030 goals if regulation stabilizes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Naturgy Energy Group SA published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.
- Naturgy-backed analysis by EY flagged Spain’s current execution pace as insufficient to meet many 2030 PNIEC energy-transition targets.
- Emissions cuts are tracking below plan, with the widest shortfalls in transport, buildings, agriculture, waste, and broader energy-efficiency goals.
- Renewables capacity is rising, but electricity demand is undershooting projections, weakening economics for new build and complicating system integration.
- Report called for faster grid buildout, more storage, clearer regulatory signals, and stronger electrification to align demand with supply.
- Biomethane outlook was more constructive, with the project pipeline seen as capable of approaching 2030 goals if regulation stabilizes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
